Gilmour Duncan 4
4 · INTEST CORP · Filed Mar 11, 2022
Insider Transaction Report
Form 4
INTEST CORPINTT
Gilmour Duncan
CFO, Treasurer & Secretary
Transactions
- Award
Common Stock
2022-03-09+6,831→ 21,604 total - Award
Common Stock
2022-03-09+6,832→ 14,773 total - Award
Employee Stock Option (right to buy)
2022-03-09+12,848→ 12,848 totalExercise: $9.76Exp: 2032-03-08→ Common Stock (12,848 underlying)
Holdings
- 200(indirect: By Spouse)
Common Stock
Footnotes (3)
- [F1]The shares acquired are restricted shares issued pursuant to the Issuer's Third Amended and Restated 2014 Stock Plan (the "Plan") and will vest 25% annually commencing on March 9, 2023.
- [F2]The shares acquired are performance-based restricted shares issued pursuant to the Plan and will vest on March 9, 2025 dependent upon certain performance criteria. The amount shown reflects the number of shares that will vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 10,247.
- [F3]The option was issued pursuant to the Plan and will vest 25% annual commencing on March 9, 2023.